Breast cancer research at the Gulbenkian Institute for Molecular Medicine (GIMM) focuses on understanding the fundamental biological processes that drive the development and progression of breast cancer. Scientists at GIMM investigate tumor biology, genetic and epigenetic factors, and resistance mechanisms to current treatments. By integrating advanced molecular techniques, personalized medicine strategies, and innovative therapeutic approaches, GIMM aims to develop more effective diagnostic tools and targeted therapies, ultimately improving patient survival and quality of life.